Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The objective of this meta-analysis is to provide data on long-term safety and efficacy
following the recent positive Committee for Medicinal Products for Human Use (CHMP) opinion
for retigabine using pooled data from ongoing open-label extension (OLE) Studies
VRX-RET-E22-303 and VRX-RET-E22-304.